EUVIMEDEUVIMED entdecken
Open Access

A Cathepsin‐Triggered Size‐Shrinkable Nanoparticle Enhances Fibrous Cap Penetration to Relieve Atherosclerosis

Xiaoya Liang, Maochang Xu, Daobin Wu, Xinghui He, Yilin Liu, Xiao Tan, Qi Li, Ziyi Liu, Yan Wei, Ping Yang iD, Chunhong Li iD

Advanced Healthcare Materials · 2026-08 · 15 (32)

DOI: 10.1002/adhm.71502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 29.07.2026. Verfasst von Xiaoya Liang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Nanoparticles, Atherosclerosis, Cathepsin K. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Luzhou Municipal People's Government-Southwest Medical University Joint Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the microenvironment of atherosclerosis (AS), excessive migration of vascular smooth muscle cells led to the formation of a thick fibrous cap. This structure acted as a physical barrier and hindered efficient drug delivery to lesional macrophages. An optimal strategy for balancing long circulation with effective penetration involved the use of size‐tunable nanoformulations. Leveraging highly expressed cathepsin K (CTSK) in atherosclerotic plaques, this work reported CTSK‐responsive, size‐shrinkable nanoparticles (PDE@Mn 3 O 4 /SIM) by encapsulating trimanganese tetraoxide (Mn 3 O 4 ) and simvastatin (SIM) within CTSK‐cleavable block copolymers (PDE) to achieve controlled drug release and deep penetration within plaque sites. The resulting nanoparticles underwent rapid degradation and released smaller Mn 3 O 4 nanozymes, facilitating penetration into plaque macrophages. In vitro, the nanoparticles reduced reactive oxygen species levels and enhanced cholesterol efflux in macrophages. More importantly, they prolonged blood circulation and selectively accumulated in atherosclerotic plaques with high enzyme expression. They also markedly decreased macrophage infiltration and lipid deposition in plaques of AS mouse models. Collectively, these findings indicated that nanoparticles with CTSK‐responsive and size‐regulating properties achieved deep plaque penetration and precise macrophage targeting, serving as an effective anti‐atherosclerotic therapeutic strategy. Highlights Utilizing endogenously overexpressed cathepsin K in plaques as a biological stimulus could achieve precise and on‐demand drug release. By taking advantage of the size restriction imposed by fibrous caps, we designed microenvironment‐adaptive and size‐transformable nanoparticles for deep penetration. Co‐delivery of Mn 3 O 4 nanozyme and SIM elicited synergistic antioxidative, antiinflammatory and lipid‐modulating activities to combat atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesAtherosclerosisCathepsin KAnimalsMiceSimvastatinMacrophagesPlaque, AtheroscleroticOxidesManganese CompoundsMaleRAW 264.7 CellsMice, Inbred C57BLReactive Oxygen Species

Stichwörter der Autor:innen

CTSK‐responsive nanoparticleatherosclerosisfibrous cap penetrationultra‐small Mn3O4 nanozyme

Substanzen

Cathepsin KSimvastatinOxidesManganese Compoundsmanganese oxideReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
  • Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
  • Key Laboratory of Medical Electrophysiology, Institute of Cardiovascular Research, Southwest Medical University, Luzhou, Sichuan, China.
  • Department of Cardiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.

ORCID-Profile: Ping Yang, Chunhong Li

Förderung

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • Luzhou Municipal People's Government-Southwest Medical University Joint Scientific Research Project

Zitieren

APA

Liang, X., Xu, M., Wu, D., He, X., Liu, Y., Tan, X., Li, Q., Liu, Z., Wei, Y., Yang, P., & Li, C. (2026). A Cathepsin‐Triggered Size‐Shrinkable Nanoparticle Enhances Fibrous Cap Penetration to Relieve Atherosclerosis. Advanced Healthcare Materials, 15(32). https://doi.org/10.1002/adhm.71502

Vancouver

Liang X, Xu M, Wu D, He X, Liu Y, Tan X, et al. A Cathepsin‐Triggered Size‐Shrinkable Nanoparticle Enhances Fibrous Cap Penetration to Relieve Atherosclerosis. Advanced Healthcare Materials. 2026;15(32). doi:10.1002/adhm.71502

BibTeX
@article{Liang2026,
  author = {Liang, Xiaoya and Xu, Maochang and Wu, Daobin and He, Xinghui and Liu, Yilin and Tan, Xiao and Li, Qi and Liu, Ziyi and Wei, Yan and Yang, Ping and Li, Chunhong},
  title = {A Cathepsin‐Triggered Size‐Shrinkable Nanoparticle Enhances Fibrous Cap Penetration to Relieve Atherosclerosis},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {32},
  doi = {10.1002/adhm.71502}
}
Kostenlos starten →